Search alternatives:
teer decrease » greater decrease (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 821 - 840 results of 44,204 for search '(( 50 ((ms decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (mean decrease)) ))', query time: 1.19s Refine Results
  1. 821
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 822
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 823
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 824
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 825
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 826
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 827
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 828
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 829
    Mean score and proportion of selected items among women gave birth in Hossana town administration, southern Ethiopia, 2018.

    Mean score and proportion of selected items among women gave birth in Hossana town administration, southern Ethiopia, 2018. by Getachew Ossabo Babore (10788843)

    Published 2021
    Save to List
    Saved in:
  10. 830
    Inflammatory conditions decrease CD36 expression and CD36-mediated <i>Pf</i>PEs phagocytosis through downregulation of PPARγ.

    Inflammatory conditions decrease CD36 expression and CD36-mediated <i>Pf</i>PEs phagocytosis through downregulation of PPARγ. by David Olagnier (205583)

    Published 2011
    Save to List
    Saved in:
  11. 831
    Expression of vTR harboring the mutant template (AU5) decreases cell proliferation of an avian cancer cell line.

    Expression of vTR harboring the mutant template (AU5) decreases cell proliferation of an avian cancer cell line. by Benedikt B. Kaufer (341018)

    Published 2013
    Save to List
    Saved in:
  12. 832
    E<sub>50</sub> values of angle.

    E<sub>50</sub> values of angle. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  13. 833
    Curve fitting of E<sub>50</sub>.

    Curve fitting of E<sub>50</sub>. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  14. 834
    Fitting curves of E<sub>50</sub>.

    Fitting curves of E<sub>50</sub>. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  15. 835
    E<sub>50</sub> values of size.

    E<sub>50</sub> values of size. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  16. 836
    E<sub>50</sub> fluctuation coefficient.

    E<sub>50</sub> fluctuation coefficient. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  17. 837
    Fitting relationship of E<sub>50</sub>.

    Fitting relationship of E<sub>50</sub>. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  18. 838
    Fitting curve of E<sub>50</sub>.

    Fitting curve of E<sub>50</sub>. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  19. 839
    The T-type channel antagonist Ni<sup>2+</sup> decreases adult turtle motoneuron excitability.

    The T-type channel antagonist Ni<sup>2+</sup> decreases adult turtle motoneuron excitability. by Martha Canto-Bustos (634777)

    Published 2014
    Save to List
    Saved in:
  20. 840
    Box plot JRS, EQ-5D-5L, and NEI-VFQ-25 at each visit.

    Box plot JRS, EQ-5D-5L, and NEI-VFQ-25 at each visit. by Parima Hirunwiwatkul (14797370)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: